Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis

BACKGROUND: Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease. Great efforts have been recently made to treat AD using mesenchymal stem cells (MSCs), which have immunomodulatory functions. However, the immunomodulatory effects of MSCs need to be enhanced for clinical applic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Stem Cell Res Ther
Главные авторы: Park, Arum, Park, Hyojung, Yoon, Jisun, Kang, Dayeon, Kang, Myoung-Hee, Park, Y-Y, Suh, Nayoung, Yu, Jinho
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2019
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6387524/
https://ncbi.nlm.nih.gov/pubmed/30795812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-019-1164-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы